长期缓解的炎症性肠病患者骨量减低而骨髓脂肪组织保留
研究纳入21例克罗恩病和15例溃疡性结肠炎长期无激素缓解患者及65例对照,用双能X线和磁共振波谱评估骨量与L3椎体骨髓脂肪组织。两组患者L1-L4的Z值≤-2.0比例均显著高于对照,但L3骨髓脂肪组织与对照无显著差异。结论认为长期缓解的炎症性肠病患者可能骨量低而骨髓脂肪组织保留。
要点
- 克罗恩病和溃疡性结肠炎长期无激素缓解患者L1-L4的Z值≤-2.0比例显著高于对照。
- 克罗恩病患者股骨颈和全髋T值<-1.0比例显著高于对照。
- L3骨髓脂肪组织在炎症性肠病组与对照组间无统计学显著差异。
核心结论
- 长期无激素缓解的炎症性肠病患者可能骨量低而骨髓脂肪组织保留。
- 这些发现证实炎症性肠病骨病的异质性,并可能提示活动性疾病中骨丢失相关因素对患者有长期影响。
研究设计与样本
- 研究纳入克罗恩病21例、溃疡性结肠炎15例和对照65例,采用双能X线吸收法和L3腰椎磁共振波谱评估骨髓脂肪组织。
主要发现
- L1-L4的Z值≤-2.0比例:对照1.54% vs 克罗恩病19.05% vs 溃疡性结肠炎20%(p=0.02),其他部位无显著差异。
- 股骨颈T值<-1.0比例:对照18.46% vs 克罗恩病47.62%(p=0.02)。
- 全髋T值<-1.0比例:对照16.92% vs 克罗恩病42.86%(p=0.03)。
- L3骨髓脂肪组织:对照28.62±8.15% vs 克罗恩病29.81±6.90% vs 溃疡性结肠炎27.35±9.80%(p=0.67),无统计学显著差异。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
UNLABELLED: Bone marrow adipose tissue has not been studied in patients with inactive inflammatory bowel disease. We found that these patients have preserved marrow adiposity even with low bone mass. Factors involved in bone loss in active disease may have long-lasting effects but do not seem to affect bone marrow adiposity. INTRODUCTION: Reduced bone mass is known to occur at varying prevalence in patients with inflammatory bowel diseases (IBD) because of inflammation, malnutrition, and steroid therapy. Osteoporosis may develop in these patients as the result of an imbalanced relationship between osteoblasts and adipocytes in bone marrow. This study aimed to evaluate for the first time bone mass and bone marrow adipose tissue (BMAT) in a particular subgroup of IBD patients characterized by long-term, steroid-free remission. METHODS: Patients with Crohn's disease (CD; N = 21) and ulcerative colitis (UC; N = 15) and controls (C; N = 65) underwent dual X-ray energy absorptiometry and nuclear magnetic resonance spectroscopy of the L3 lumbar vertebra for BMAT assessment. RESULTS: Both the CD and UC subgroups showed significantly higher proportions of patients than controls with Z-score ≤-2.0 at L1-L4 (C 1.54%; CD 19.05%; UC 20%; p = 0.02), but not at other sites. The proportions of CD patients with a T-score ˂-1.0 at the femoral neck (C 18.46%; CD 47.62%; p = 0.02) and total hip (C 16.92%; CD 42.86%; p = 0.03) were significantly higher than among controls. There were no statistically significant differences between IBD patients and controls regarding BMAT at L3 (C 28.62 ± 8.15%; CD 29.81 ± 6.90%; UC 27.35 ± 9.80%; p = 0.67). CONCLUSIONS: IBD patients in long-term, steroid-free remission may have a low bone mass in spite of preserved BMAT. These findings confirm the heterogeneity of bone disorders in IBD and may indicate that factors involved in bone loss in active disease may have long-lasting effects on these patients.
引用
- Bastos CM, Araújo IM, Nogueira-Barbosa MH, et al. Reduced bone mass and preserved marrow adipose tissue in patients with inflammatory bowel diseases in long-term remission. Osteoporos Int. 2017. PMID: 28405731. doi:10.1007/s00198-017-4014-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。